Stigma, Discrimination and Disclosure of the Diagnosis of Multiple Sclerosis in the Workplace: A Systematic Review.

demyelinating disease discrimination job multiple sclerosis neurology occupational medicine stigma work

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
02 08 2022
Historique:
received: 29 06 2022
revised: 18 07 2022
accepted: 23 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 16 8 2022
Statut: epublish

Résumé

The objective of the study was to describe and analyze the stigma, discrimination and the disclosure of the diagnosis of Multiple Sclerosis (MS) in the workplace. The protocol was registered in PROSPERO (CRD42022320437). We systematically searched four scientific databases with key search terms. We included any original peer-reviewed articles reporting the stigma or discrimination experienced at work due to MS or the disclosure of the diagnosis of MS in the workplace. No time limits were set for the search. An appraisal of the individual study quality was performed with the JBI critical appraisal checklist. Overall, 26 studies were deemed to fulfil all the eligibility criteria. The total number of participants in this review was 9571. The prevalence of people with MS who experience some degree of stigma in the workplace can be as high as 79.2%. Those who report greater feelings of discrimination are more likely to be unemployed. The prevalence of employers' and co-workers' awareness of the diagnosis varies from 31.7 to 90.2%. The main reason for non-disclosure is the fear of being discriminated against. The psychosocial work environment needs to be taken into consideration as part of public and individual policies to promote the health of patients with MS.

Identifiants

pubmed: 35954811
pii: ijerph19159452
doi: 10.3390/ijerph19159452
pmc: PMC9367867
pii:
doi:

Types de publication

Journal Article Review Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Mult Scler. 2014 Jan;20(1):116-9
pubmed: 23842211
Acta Neurol Taiwan. 2018 Mar 15;27(1):1-8
pubmed: 30315555
BMC Psychiatry. 2020 Jun 8;20(1):288
pubmed: 32513133
Mult Scler. 2007 Nov;13(9):1183-9
pubmed: 17623726
J Rehabil Med. 2016 Jun 13;48(6):535-40
pubmed: 27243419
PLoS One. 2021 Aug 5;16(8):e0255697
pubmed: 34351965
Arch Phys Med Rehabil. 2021 Aug;102(8):1556-1561
pubmed: 33684369
Rev Neurol (Paris). 2016 Jan;172(1):3-13
pubmed: 26718593
Int J MS Care. 2020 Jul-Aug;22(4):158-164
pubmed: 32863783
Lancet. 2012 Oct 27;380(9852):1491-7
pubmed: 22981903
Arch Phys Med Rehabil. 2018 Feb;99(2):272-280
pubmed: 28928026
Work. 1996;7(1):37-46
pubmed: 24441620
Nat Rev Dis Primers. 2018 Nov 8;4(1):43
pubmed: 30410033
BMC Psychiatry. 2016 Jan 06;16:1
pubmed: 26739960
Disabil Rehabil. 2014;36(8):635-41
pubmed: 23786346
Psychol Med. 2017 Jun;47(8):1342-1356
pubmed: 28122650
J Med Educ Curric Dev. 2021 May 26;8:23821205211018696
pubmed: 34104788
Ann Agric Environ Med. 2021 Mar 18;28(1):99-106
pubmed: 33775074
J Occup Rehabil. 2021 Mar;31(1):153-165
pubmed: 32410153
Psychooncology. 2015 May;24(5):508-14
pubmed: 25251666
Mult Scler Relat Disord. 2020 Jun;41:102046
pubmed: 32179482
Mult Scler. 2021 Jun;27(7):1125-1135
pubmed: 32757907
Disabil Rehabil. 2015;37(4):319-26
pubmed: 25520059
Ann Readapt Med Phys. 2008 Jun;51(5):386-93
pubmed: 18565608
Mult Scler Relat Disord. 2015 Sep;4(5):409-413
pubmed: 26346789
J Occup Rehabil. 2021 Sep 6;:
pubmed: 34487290
J Occup Rehabil. 1993 Jun;3(2):113-7
pubmed: 24243231
Mult Scler Relat Disord. 2021 May;50:102860
pubmed: 33647591
Rev Neurol (Paris). 2015 Nov;171(11):782-6
pubmed: 26343923
Mult Scler. 2017 Aug;23(2_suppl):192-203
pubmed: 28643596
Mult Scler. 2014 Jun;20(7):871-6
pubmed: 24263383
Mult Scler. 2015 Feb;21(2):225-34
pubmed: 25070678
Int J MS Care. 2019 Sep-Oct;21(5):214-225
pubmed: 31680783
Work. 2015;52(4):735-48
pubmed: 26599671
BMJ Open. 2022 Jul 1;12(7):e058948
pubmed: 35777874
Disabil Rehabil. 2017 May;39(9):867-873
pubmed: 28293978
Occup Environ Med. 2021 Feb 4;:
pubmed: 33542095
CMAJ. 2016 Dec 6;188(17-18):E447-E455
pubmed: 27698195
Early Interv Psychiatry. 2016 Apr;10(2):178-85
pubmed: 25345473

Auteurs

Bruno Kusznir Vitturi (BK)

Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.

Alborz Rahmani (A)

Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Occupational Medicine Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Guglielmo Dini (G)

Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Occupational Medicine Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Alfredo Montecucco (A)

Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Occupational Medicine Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Nicoletta Debarbieri (N)

Occupational Medicine Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Paolo Bandiera (P)

Italian Multiple Sclerosis Association (AISM), 16126 Genoa, Italy.

Michela Ponzio (M)

Scientific Research Area, Italian Multiple Sclerosis Foundation (FISM), 16126 Genoa, Italy.

Mario Alberto Battaglia (MA)

Scientific Research Area, Italian Multiple Sclerosis Foundation (FISM), 16126 Genoa, Italy.
Department of Life Science, University of Siena, 53100 Siena, Italy.

Benedetta Persechino (B)

Italian Workers' Compensation Authority (INAIL), 00078 Rome, Italy.

Matilde Inglese (M)

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, 16132 Genoa, Italy.
Neurology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Paolo Durando (P)

Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Occupational Medicine Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH